azides has been researched along with Idiopathic Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chamot-Rooke, J; Dautrey, S; Melki, R; Nury, C; Redeker, V; Renard, PY; Romieu, A; van der Rest, G | 1 |
| Gerlach, J | 1 |
| Fassos, FF; Fogel, EF; Niznik, HB; Seeman, P | 1 |
1 trial(s) available for azides and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial.
Topics: Aged; Azides; Benserazide; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Ergolines; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychoses, Substance-Induced | 1976 |
2 other study(ies) available for azides and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
A novel bio-orthogonal cross-linker for improved protein/protein interaction analysis.
Topics: alpha-Synuclein; Amino Acid Sequence; Azides; Carbamates; Chromatography, Liquid; Cross-Linking Reagents; HSC70 Heat-Shock Proteins; Humans; Mass Spectrometry; Models, Molecular; Molecular Sequence Data; Parkinson Disease; Protein Interaction Mapping; Protein Interaction Maps | 2015 |
The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus.
Topics: Affinity Labels; Aged; Azides; Binding Sites; Binding, Competitive; Carrier Proteins; Caudate Nucleus; Chromatography; Dopamine Plasma Membrane Transport Proteins; Humans; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Molecular Weight; Nerve Tissue Proteins; Parkinson Disease; Photochemistry; Piperazines; Putamen; Wheat Germ Agglutinins | 1991 |